Saudi Pharmaceutical Industries and Medical Appliances Corporation

TADAWUL:2070.SR

33.95 (SAR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 373.378475331381.62408.724532.101369.36357.023310.624451.271365.441312.016326.681455.646368.791378.979160.472202.395615.702280.215300.528356.07357.588213.698312.739390.793410.787277.607304.634393.104458.145375.203495.938511.908528.785308.267435.803432.195427.816266.019374.137402.214376.349219.131344.217361.374427.721227.399
Cost of Revenue 195.978223229215.642225.233275.168232.1233.768189.599266.489207.55165.898157.919313.366240.225178.595175.727276.996498.83105.442199.796196.773215.14999.148146.644193.477203.614148.928148.505180.524213.124205.094253.905259.69264.806176.948224.858206.336167.599131.564180.683195.803152.37103.652165.102176.753154.812114.119
Gross Profit 177.4252102165.978183.491256.933137.26123.255121.025184.781157.891146.118168.762142.279128.567200.384-15.254-74.601116.871174.773100.732159.298142.439114.55166.096197.317207.173128.679156.129212.58245.021170.109242.033252.218263.979131.319210.945225.86260.217134.454193.454206.411223.979115.479179.115184.622272.909113.28
Gross Profit Ratio 0.4750.5310.3080.4350.4490.4830.3720.3450.390.4090.4320.4680.5170.3120.3490.529-0.095-0.3690.190.6240.3350.4470.3980.5360.5310.5050.5040.4640.5130.5410.5350.4530.4880.4930.4990.4260.4840.5230.6080.5050.5170.5130.5950.5270.520.5110.6380.498
Reseach & Development Expenses 13.25217107.50711.04212.64433.7454.9611.1912.7482.9591.1212.4341.5529.1397.3462.1231.8058.0378.0227.7998.20516.0428.1646.8899.4829.82411.4598.5387.678.9166.3228.3867.68325.3470002.841000000000
General & Administrative Expenses 54.12167.053-110.88566.55157.51863.142-123.71974.45572.25857.829-92.51146.12462.64448.66647.35450.19848.85754.023-92.0646.66354.79437.86450.9158.59945.88531.75628.13434.13328.90235.79919.58536.04339.86430.9228.32618.58321.75523.81321.22317.820.74419.606-19.28316.34717.33718.12715.10311.23
Selling & Marketing Expenses 70.14380.576-167.8383.82180.41599.066-180.5581.47296.93880.359-168.54282.30282.54475.58888.80670.88282.83975.739-100.21768.82697.52684.812103.15867.53692.50685.34592.85874.78369.289119.077203.259112.117147.237130.245137.67688.042141.171110.702149.26885.388130.1108.464-33.17865.758121.14395.853133.1962.442
SG&A 133.554148154150.372137.933162.207-304.269155.927169.196138.188-261.053128.426145.189124.254138.867121.08131.697129.761-192.277115.489182.295122.676149.96126.135139.771117.101126.06108.91598.192154.876226.748148.161187.102161.165166.002106.624162.927134.515170.49103.188150.844128.07-52.46282.105138.48113.98148.29373.672
Other Expenses 5.355-133.064-28.9471.418-13.11476.3439.6674.156-8.543-20.602-0.617.4655.857-123.807-122.892-117.984-149.631.4532.33-175.1273.8760-110.979-114.641-127.788-480.9990.09-96.675-161.101276.8082.412-1.0222.0610.4510.1121.090.097-0.1030.1961.6680.512-0.3080.1962.6041.65800.112
Operating Expenses 146.806165164157.879148.975174.852205.818160.888170.387140.936176.307129.547147.623125.806-123.807-122.892-117.984-149.63230.49123.51-175.127130.881127.289-110.979-114.641-127.788-480.9990.09-96.675-161.101276.808148.161187.102161.165166.002106.624162.927134.515170.49103.188150.844128.07160.25182.105138.48113.98148.29373.672
Operating Income 30.59487-62-16.59635.08969.418-68.558-37.633-49.36337.277-19.26118.24731.01225.5044.75977.49342.48952.765-277.93751.384-74.3953.163142.4393.57151.45469.529-273.826128.76959.45451.479-7.63221.94854.93191.05397.97724.69448.01891.34589.72631.26642.6178.34261.50633.37440.63570.64262.86139.608
Operating Income Ratio 0.0820.183-0.187-0.0430.0860.13-0.186-0.105-0.1590.083-0.0530.0580.0950.0560.0130.2040.2650.261-0.4510.183-0.2480.0090.3980.0170.1650.178-0.6670.4640.1950.131-0.0170.0580.1110.1780.1850.080.110.2110.210.1180.1140.1950.1630.1520.1180.1950.1470.174
Total Other Income Expenses Net -5.009-4141-17.431-9.984-3.801-31.989-2.2135.9221.307-7.543-1.888-2.1310.036-2.951-4.618-9.242-2.721-14.473-14.885-112.831-3.319-239.123-6.68-15.969-13.684362.436-120.544-6.03648.467227.717-7.764.98224.943-106.1468.995196.52414.6914.5859.85862.62520.35179.3884.78378.0870.5650.843-2.919
Income Before Tax 25.58546-21-34.02725.10565.617-100.547-39.846-43.44138.585-37.05116.35928.88125.5411.80872.87533.24750.044-292.4136.498-187.226-0.156-96.684-3.10935.48655.84588.6118.22553.41899.946220.08514.18859.913115.996-8.16833.69244.543106.03694.31141.124105.23598.69358.29138.157118.72271.20258.77136.689
Income Before Tax Ratio 0.0690.097-0.063-0.0890.0610.123-0.272-0.112-0.140.086-0.1010.0520.0880.0560.0050.1920.2070.247-0.4750.13-0.623-0-0.27-0.0150.1130.1430.2160.030.1750.2540.480.0380.1210.227-0.0150.1090.5610.2450.220.1550.2810.2450.1550.1740.3450.1970.1370.161
Income Tax Expense -0.7677294.3733.1218.8323.6825.9958.4436.8641.6479.966-0.0780.8117.95710.3747.988.21210.9386.4361.30912.995-110.315-1.135-11.0780.61546.9550.3036.854-1.2718.327.4338.2829.4570.9484.5346.9156.6483.0264.4347.5227.52883.8874.575.0148.05460.0094.341
Net Income 33.11435.609-43-40.97122.29254.745-104.229-45.84-51.88433.325-38.1547.39731.06526.146-13.19867.40624.97945.6-269.5428.113-182.629-12.34213.631-1.97446.56455.2341.6567.92246.564101.217211.7656.75639.61488.914-9.11729.155237.62799.38891.28536.6997.71391.16557.00734.192113.70863.14853.69532.348
Net Income Ratio 0.0890.075-0.13-0.1070.0550.103-0.282-0.128-0.1670.074-0.1040.0240.0950.057-0.0360.1780.1560.225-0.4380.1-0.608-0.0350.038-0.0090.1490.1410.1010.0290.1530.2570.4620.0180.080.174-0.0170.0950.5450.230.2130.1380.2610.2270.1510.1560.330.1750.1260.142
EPS 0.280.33-0.36-0.340.190.46-0.87-0.38-0.430.28-0.360.0620.260.22-0.110.560.210.38-2.250.27-1.52-0.10.11-0.0160.390.460.350.0660.390.841.760.0560.430.89-0.0760.241.980.830.760.310.870.760.480.281.450.530.450.27
EPS Diluted 0.280.33-0.36-0.340.190.46-0.87-0.38-0.430.28-0.350.0620.260.22-0.110.560.210.38-2.250.27-1.52-0.10.11-0.0160.390.460.350.0660.390.841.760.0560.430.89-0.0760.241.980.830.760.310.870.760.480.281.450.530.450.27
EBITDA 51.674107-455.8262.26797.679-58.575-0.818-17.33463.266-12.59938.58158.27247.77430.93577.49342.48957.561-198.01349.829-74.39547.111-68.4343.57151.45469.529-202.373128.76959.45451.479235.78919.62263.314102.921263.06334.353245.036106.28295.03141.973105.85699.06543.42644.281119.35170.64263.12539.72
EBITDA Ratio 0.1380.225-0.1360.0150.1520.184-0.159-0.002-0.0560.14-0.0340.1240.1780.1050.0840.2040.2650.284-0.3220.178-0.2480.132-0.1910.0170.1650.178-0.4930.4640.1950.1310.5150.0520.1280.2010.4970.1110.5620.2460.2220.1580.2830.2460.1150.2020.3470.1950.1480.175